Research and development of protein arrays and their applications in proteomics

+44 (0)1223 496557

MENU menu

Close close menu



CDI NextGen Proteomics


The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible today the protein discoveries of tomorrow. CDI protein microarrays and related services make possible rapid, efficient analysis of thousands of protein interactions while preserving valuable clinical samples. The Company's microarray-powered monoclonal antibodies (MAbs) and MAb-related services provide unprecedented levels of specificity. The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico (PR).




YUMAB GmbH is a private SME founded in 2012. YUMAB's advanced proprietary in vitro phage display selection technology and world's largest universal naïve human antibody gene libraries allow fast track and large scale generation of recombinant monoclonal antibodies. YUMAB provides tailor-made solutions and license options for all application areas.




PolyAn is a nanotechnology company specialised in Molecular Surface Engineering (MSE). PolyAn provides solutions for multiplex diagnostic and lifesciences research applications. PolyAn offers one of the broadest product portfolios for microarray substrates on the market, e.g. plastic and glass slides as well as functionalised 96-well microplates for DNA-, peptide-, glycan- or protein microarrays. Additionally, PolyAn is producing monodisperse PMMA microparticles (beads) for multiplex bead assays, calibration and flow cytometry.